OMB APPROVAL
	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549			OMB Number: 3235-0080 Expires: February 28, 2009 Estimated average burden hours per response........1.00

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 001-15601

Biomet, Inc.; The NASDAQ Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

56 East Bell Drive; Warsaw, Indiana 46582; (425) 451-8060

(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)

Common Shares; Preferred Share Purchase Rights

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

o 17 CFR 240.12d2-2(a)(1)

o 17 CFR 240.12d2-2(a)(2)

o 17 CFR 240.12d2-2(a)(3)

o 17 CFR 240.12d2-2(a)(4)

o Pursuant to 17 CFR 240-12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.(1)

ý Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange. **

**   This Notification relates solely to the withdrawal from listing of the Preferred Share Purchase Rights from The NASDAQ Stock Market LLC.  This notification shall have no effect upon the continued listing of the Common Shares on The NASDAQ Stock Market LLC.

Pursuant to the requirements of the Securities Exchange Act of 1934, Biomet, Inc. (Name of Issuer or Exchange) certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

DATE:	December 18, 2006		BY:	/s/ Bradley J. Tandy		(Vice President, Acting General Counsel and Secretary and Corporate Compliance Officer)
			NAME:	Bradley J. Tandy		Title

 

(1)   Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable.  See General Instructions.

SEC 1654(03-06)

Persons who respond to the collection of information contained in this  form are not required to respond unless the form displays a currently valid OMB control number.